ESR1 and breast cancer: In this study, we have examined a range of human cohorts and used in vivo, in vitro and in silico approaches to identify distinct pathways associated with ER and PR in normal breast, and the convergence of their action in breast cancer, to derive ER-PR focussed prognostic tools to identify different prognosis groups within breast cancers with otherwise good prognosis.